Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychiatric drugs
Research
Arialys presents promising data for IgG1 antibody treatment
Arialys' precision therapy has shown early potential to be the first therapy to treat anti-NMDA receptor encephalitis.
Kevin Dunleavy
Jun 20, 2025 5:02am
AbbVie makes Richter richer, paying $25M to form discovery pact
Oct 25, 2024 7:55am
AbbVie pens $2B-plus neuro pact with Gilgamesh
May 13, 2024 5:57pm
Headlands acquires Pharmasite to expand mental health trials
Feb 29, 2024 4:20pm
Alto Neuroscience preps IPO to push CNS therapies through clinic
Jan 16, 2024 6:51am
Oryzon med fails to improve borderline personality disorder
Jan 7, 2024 4:17pm
